Stanford University
Showing 1,201-1,250 of 3,577 Results
-
Jacob Fouad Shafik
Undergraduate, Biology
BioHello! I'm an aspiring oncologist with an affinity for community at Stanford University.
If you're interested in connecting or have any opportunities in research, shadowing, and volunteering, please don't hesitate to reach out. I'm excited to see where my journey in medicine takes me next! -
Elaheh Shaghaghian, MD
Visiting Instructor, Neurosurgery
BioElaheh Shaghaghian, MD, is a Clinical Research Scholar at Stanford University's Neurosurgery Department, where she investigates the efficacy of CyberKnife Radiosurgery with an interdisciplinary team. Skilled in problem-solving, Elaheh has a fervent passion for learning and applying new medical technologies.
She earned her MD from Shiraz University of Medical Sciences, focusing on advancing medical treatments through research. With experience in clinical research, data analysis, and interdisciplinary collaboration, she is dedicated to leveraging technology to enhance healthcare outcomes. -
Alay Shah
Masters Student in Chemical Engineering, admitted Spring 2024
Bio→ Graduate Chemical Engineering student.
→ Previously, Process Engineer at Kite, a Gilead Company.
→ Bachelors in Biomedical Engineering at the University of Texas, Austin.
→ 5 years of experience working in cGMP pharmaceutical manufacturing and upstream process development. Working knowledge of cell and gene therapy, lean manufacturing, risk assessment &mitigation, IOPQ Validation, quality systems, eQRMS, asset lifecycle management, SAP ERP, Syncade MES, Oracle EBS, LIMS, ISO standards and FDA regulations.
→ Through Stanford's MS program, I aim to build upon my biomanufacturing experience, further developing my skillsets in bioreactor design and data analytics to model and improve standardized development of therapeutics for patients -
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioDr. Shah joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine. Dr. Shah completed medical school at the University of North Carolina- Chapel Hill. She completed her training in Pediatrics and Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. Her areas of clinical expertise have been in stem cell transplantation for malignant and non-malignant disorders. She has been actively involved with the care and treatment of children with primary immune deficiencies and is the site PI for the Primary Immune Deficiencies Consortium (PIDTC). She has experience in numerous gene therapy trials for primary immune deficiencies, hemoglobinopathies and other genetic diseases. She has a specific interest in the long term outcomes following HSCT, in specific the neurocognitive function post HSCT. She has been an active participant in American Society of Transplantation and Cellular Therapy (ASTCT), Children's Oncology Group (COG) and American Society of Hematology (ASH).
She has been actively involved with mentorship and graduate medical education, and currently serves as the Program Director for the Pediatric Hematology/ Oncology Fellowship and the Pediatric Stem Cell Fellowship. She also serves on the Pediatric Mentoring Group. -
DiPali Shah
Affiliate, Graduate School of Business - Executive Education
BioDiPali Shah is a Silicon Valley real estate broker, entrepreneur, and strategic operator with nearly three decades of experience advising founders, executives, investors, and multigenerational families on complex real estate and capital decisions. Her work focuses on luxury estates, strategic acquisitions, private negotiations, and high-value off-market transactions where discretion, trust, and long-term judgment are essential.
Over the course of her career, DiPali has represented the sale and acquisition of multimillion-dollar properties throughout Silicon Valley and the San Francisco Bay Area, including transactions exceeding $16 million in Atherton and luxury properties ranging from $4–10+ million across Los Altos Hills, Woodside, Palo Alto, Emerald Hills, and surrounding markets. She is known for navigating complex negotiations, relationship-driven transactions, and high-stakes decision-making environments where confidentiality and strategic insight are paramount.
Prior to real estate, DiPali worked as a market maker at the Pacific Stock Exchange and in clinical hospital environments in San Francisco and Oakland. These early experiences shaped her approach to probabilistic thinking, behavioral dynamics, and decision-making under uncertainty, perspectives that continue to inform her work across real estate, entrepreneurship, and emerging technologies.
DiPali is an alumna of the Stanford Graduate School of Business through the Stanford Executive Program (SEP) and a graduate of the University of California, Berkeley.
Her current work and research interests focus on the intersection of artificial intelligence, behavioral psychology, markets, and trust-based systems, with particular emphasis on how emerging technologies are reshaping human decision-making, capital allocation, and institutional behavior. She is developing entrepreneurial ventures and strategic initiatives related to AI infrastructure, digital trust systems, and technology-enabled platforms designed for high-stakes and relationship-driven environments.
Her broader interests include global business trends, negotiation strategy, emerging technologies, economic systems, and the psychology of human behavior. She speaks English, Gujarati, and Spanish, with proficiency in Mandarin. -
Jay Shah
Associate Professor of Urology
BioDr. Jay Shah, MD currently serves as Immediate Past Chief of the Medical Staff for Stanford Health Care. He is a cancer surgeon and associate professor of Urology at the Stanford University School of Medicine. His clinical focus is on bladder cancer, and he is well known for his expertise in robotic surgery. Since his arrival to Stanford, he has started the Urology Department Quality Program, the Urologic Oncology Fellowship, the Urology Resident Coaching Program, and the Inpatient Urology Hospitalist Program. His academic interests center on optimizing outcomes after bladder cancer treatment. He is very active in leadership development, team building, and quality improvement work and he lectures nationally and internationally on these topics. He is certified by the International Coaching Federation as an executive coach. He also serves as a Training Group facilitator for the highly popular course, Interpersonal Dynamics, at the Stanford Graduate School of Business.
Dr. Shah graduated from Harvard College, and he completed medical school and urology residency training at Columbia University. During his time at Columbia, Dr. Shah was elected to the Alpha Omega Alpha Medical Honor Society; he was named Physician of the Year by the nursing staff; and he was recognized by the medical students with the Gold Foundation Excellence in Teaching Award. After residency, he completed a three-year fellowship in Urologic Oncology at MD Anderson Cancer Center and then joined the faculty there. During his time at MD Anderson, Dr. Shah launched the bladder cancer robotics program, developed an enhanced recovery program for patients undergoing bladder removal surgery, became double board-certified in Urology and Medical Quality, and was chosen to lead the MDACC Genitourinary Center as Center Medical Director.
In his free time, Dr. Shah enjoys reading, cooking, growing his own food, surfing, and exploring the beaches of Northern California with his three dogs. -
Mamta Madhav Shah, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Shah is a board-certified, fellowship-trained nephrologist and clinical assistant professor in the Department of Medicine, Division of Nephrology at Stanford University School of Medicine.
She completed her residency and fellowship training in Connecticut and was faculty at the University of Connecticut Health Center before moving to the Bay Area and Stanford. She provides care for patients with a variety of kidney-related conditions, with a special interest and clinical focus in metabolic evaluation and prevention of kidney stones. Her goal is to collaborate with each patient to develop a personalized and comprehensive care plan. She has given many talks on management of kidney stones to peers and trainees. She also has an interest in inpatient nephrology. Dr. Shah previously served as medical director of a University of Connecticut Health Center affiliated dialysis clinic during her time there, and helped run the plasmapheresis treatments. She continues to care for chronic hemodialysis patients since moving to Stanford.
Dr. Shah is a member and fellow of the American Society of Nephrology. She is closely involved in the education of trainees including medical students, residents and fellows. She served as core faculty of the Nephrology Fellowship at the University of Connecticut Health Center and continues to be involved in the fellowship training at Stanford as site director for the Nephrology Fellowship.
Dr. Shah’s work has been published in the Journal of Onco-Nephrology, Therapeutic Apheresis and Dialysis, and Connecticut Medicine. She has presented to her peers at national and regional meetings of the American Society of Nephrology, the National Kidney Foundation, and the American College of Physicians, Connecticut Chapter.
She is fluent in Hindi and Gujarati. Outside of work she enjoys traveling and spending time with her husband and children. -
Manish I. Shah, MD, MS
Professor of Emergency Medicine (Pediatrics) and, by courtesy, of Pediatrics (Hospital Medicine)
BioI have dedicated my career to improving pediatric prehospital care on local, statewide, national, and international levels through research, education, and advocacy. My primary research interest focuses on integration of pediatric evidence into emergency medical services (EMS) systems. I serve on the Executive Committee of the Pediatric Emergency Care Applied Research Network (PECARN) as the nodal Principal Investigator (PI) for the Charlotte, Houston, and Milwaukee Prehospital (CHaMP) research node. In addition, I am the PI for the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) clinical trial and co-investigator for the Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART). As an educational researcher, I have obtained several grants to produce an online EMS educational resource for physicians, create the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program, and study the implementation of an EMS training curriculum for the Botswana Ministry of Health. As an EMS advocate, I led the Prehospital and State Partnership domains for the national EMS for Children (EMSC) Innovation and Improvement Center (EIIC), served as an appointed member of the National Emergency Medical Services Advisory Council (NEMSAC), chaired the EMS subcommittee for the American Academy of Pediatrics Section of Emergency Medicine, and directed the EMSC State Partnership in Texas. I have published policy on pediatric readiness in EMS systems and co-chaired the workgroup that created the first-ever national assessment of pediatric readiness of EMS systems for the National Prehospital Pediatric Readiness Project (PPRP).
-
Mona D. Shah, MD, MBA
Adjunct Clinical Associate Professor, Pediatrics - Hematology & Oncology
BioDr. Mona Shah is a pediatric hematologist-oncologist, who earned her MD degree at the University of Maryland in 2001. She completed both her categorical pediatrics and global health residencies in 2004, followed by a pediatric hematology-oncology fellowship in 2007. She earned her MS in Clinical Investigation as part of the Clinical Scientist Training Program (CSTP) at Baylor College of Medicine in 2011, and more recently, completed an Executive MBA at Rice University Jones School of Business in 2018.
Dr. Shah was an Associate Professor at Baylor College of Medicine (2007 - 2020) in both Pediatrics and Medicine, local site PI on a number of pediatric hemostasis/thrombosis clinical trials, and spent 10 years as an Associate Medical Director of Clinical Operations, Quality, and Safety at Texas Children’s Hospital, Houston, TX.
Dr. Shah joined Genentech (a Member of the Roche Group)’s Rare Blood Disorders Franchise (Product Development - Oncology-Hematology) in February 2020, quickly advancing to Lead Medical Director, where she served as Medical Monitor for 2 Phase III Clinical Trials (crovalimab in atypical hemolytic uremic syndrome, aHUS). She was also engaged with the Renal Franchise (I2O) in developing crovalimab in Lupus Nephritis (Phase I & II Clinical Trials in development), and with Human Factors/Pediatric Formulations Working Group on autoinjector devices and oral formulations.
After completing a rotation in Early Development Safety (EDS), she was promoted to Senior Medical Safety Director in Late Stage Product Development, and was appointed Safety Strategy Lead for giredestrant in early and metastatic breast, ovarian, and endometrial cancer global clinical trials. She has experience in innovative study designs (adaptive/multi-drug), with FDA/EMA pediatric investigational plans, and health authority interactions. In June 2023, she was appointed Pediatric Safety Lead, in collaboration with the iPODD Team, supporting safety for pediatric indications and devices, and serves as the Co-Chair of the Pediatric Safety Expert Group.
Dr. Shah has kept and completed a bucket list since she was 7 years old (keeps growing): Running wild bouldering/rock climbing as a child in the Shenandoah/Blue Ridge Mountains, swimming with dolphins/piranhas in the Amazon, climbing inside a volcano caldera in Iceland, snorkeling the Great Barrier Reef ... have passport/will travel!
Since July 2022, she has joined Stanford University School of Medicine, as an Adjunct Clinical Associate Professor in the Department of Pediatrics, Division of Hematology-Oncology, where she enjoys teaching MSII students, and at the bedside in the Lucille Packard Bass Center Hematology Clinic. Dr. Shah enjoys free time in her new home base near San Francisco, where she hosts her visiting parents, friends, and extended family. -
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Computational Medicine), of Biomedical Data Science and, by courtesy, of Computer Science
Current Research and Scholarly InterestsWe answer clinical questions using aggregate patient data at the bedside. The Informatics Consult Service (https://greenbutton.stanford.edu/) put this idea in action and led to the creation of Atropos Health. We build predictive models that allow taking mitigating actions, keeping the human in the loop.
-
Nirao Shah
Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator), of Neurobiology and, by courtesy, of Obstetrics and Gynecology
Current Research and Scholarly InterestsWe study how our brains generate social interactions that differ between the sexes. Such gender differences in behavior are regulated by sex hormones, experience, and social cues. Accordingly, we are characterizing how these internal and external factors control gene expression and neuronal physiology in the two sexes to generate behavior. We are also interested in understanding how such sex differences in the healthy brain translate to sex differences in many neuro-psychiatric illnesses.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, digital health and generative AI, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
